Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
A combination vaccine is designed to provide protection against two or more diseases or against single disease caused by completely different or similar organism. A combination vaccine also boosts the immune system to fight against infection. These vaccines contain two or more antigens that are either combined in ready form or mixed before administration. Safety, efficacy, and immunogenicity of a combined immunizing agent are high.
The increase in pediatric population is one of the primary growth factors for this market. With the increase in pediatric population, the demand for combination vaccines for immunization is higher as newborn infants are more vulnerable to various infectious diseases due to weak immune systems. These vaccines help reduce the number of shots and healthcare center visits, which consequently save time and money. It has been observed that the occurrence of viral infections and diseases such as polio, tetanus, diphtheria, smallpox, chickenpox, and measles is high among children in developing nations.The Americas is expected to be the major revenue contributor to the market by 2023. The introduction of strict regulatory norms that recommend proper vaccination of infants and the continuous efforts by vendors and national organizations to promote the use of human combination vaccines, will drive the market’s growth prospects in the Americas.
The report details the trend, potential and market size of Human Combination Vaccines market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Human Combination Vaccinesmarket, defines the market attractiveness level of Human Combination Vaccines market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Human Combination Vaccines industry, describes the types of Human Combination Vaccines market, the applications of major players and the market size, and deeply analyzes the current situation of the global Human Combination Vaccines market and the development prospects and opportunities of Human Combination Vaccines industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Human Combination Vaccines market in Chapter 13.
By Player:
Merck
Takeda Pharmaceuticals
Daiichi Sankyo
Sanofi
GlaxoSmithKline
Serum Institute of India
By Type:
Human Combination Inactivated Vaccines
Human Combination Live Attenuated Vaccines
By End-User:
Hospitals
Clinics
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Human Combination Vaccines Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Human Combination Vaccines Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Human Combination Vaccines Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Human Combination Vaccines Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Human Combination Vaccines Market Analysis and Outlook to 2022
-
7.1 Global Human Combination Vaccines Consumption (2017-2022)
-
7.2 United States Human Combination Vaccines Consumption (2017-2022)
-
7.3 Europe Human Combination Vaccines Consumption (2017-2022)
-
7.4 China Human Combination Vaccines Consumption (2017-2022)
-
7.5 Japan Human Combination Vaccines Consumption (2017-2022)
-
7.6 India Human Combination Vaccines Consumption (2017-2022)
-
7.7 South Korea Human Combination Vaccines Consumption (2017-2022)
8 Region and Country-wise Human Combination Vaccines Market Analysis and Outlook to 2028
-
8.1 Global Human Combination Vaccines Consumption Forecast (2022-2028)
-
8.2 United States Human Combination Vaccines Consumption Forecast (2022-2028)
-
8.3 Europe Human Combination Vaccines Consumption Forecast (2022-2028)
-
8.4 China Human Combination Vaccines Consumption Forecast (2022-2028)
-
8.5 Japan Human Combination Vaccines Consumption Forecast (2022-2028)
-
8.6 India Human Combination Vaccines Consumption Forecast (2022-2028)
-
8.7 South Korea Human Combination Vaccines Consumption Forecast (2022-2028)
9 Global Human Combination Vaccines Market Outlook by Types and Applications to 2022
-
9.1 Global Human Combination Vaccines Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Human Combination Inactivated Vaccines Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Human Combination Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
9.2 Global Human Combination Vaccines Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Human Combination Vaccines Market Outlook by Types and Applications to 2028
-
10.1 Global Human Combination Vaccines Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Human Combination Inactivated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Human Combination Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Human Combination Vaccines Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Human Combination Vaccines Import and Export Analysis (Top 5 Countries)
-
11.1 Global Human Combination Vaccines Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Human Combination Vaccines Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Human Combination Vaccines Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Human Combination Vaccines Market Competitive Analysis
-
14.1 Merck
-
14.1.1 Merck Company Details
-
14.1.2 Merck Human Combination Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Merck Human Combination Vaccines Product and Service
-
14.2 Takeda Pharmaceuticals
-
14.2.1 Takeda Pharmaceuticals Company Details
-
14.2.2 Takeda Pharmaceuticals Human Combination Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Takeda Pharmaceuticals Human Combination Vaccines Product and Service
-
14.3 Daiichi Sankyo
-
14.3.1 Daiichi Sankyo Company Details
-
14.3.2 Daiichi Sankyo Human Combination Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Daiichi Sankyo Human Combination Vaccines Product and Service
-
14.4 Sanofi
-
14.4.1 Sanofi Company Details
-
14.4.2 Sanofi Human Combination Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Sanofi Human Combination Vaccines Product and Service
-
14.5 GlaxoSmithKline
-
14.5.1 GlaxoSmithKline Company Details
-
14.5.2 GlaxoSmithKline Human Combination Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 GlaxoSmithKline Human Combination Vaccines Product and Service
-
14.6 Serum Institute of India
-
14.6.1 Serum Institute of India Company Details
-
14.6.2 Serum Institute of India Human Combination Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Serum Institute of India Human Combination Vaccines Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Human Combination Vaccines
-
Figure Human Combination Vaccines Picture
-
Table Global Human Combination Vaccines Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Human Combination Vaccines Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Human Combination Vaccines Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Human Combination Vaccines Consumption by Country (2017-2022)
-
Figure United States Human Combination Vaccines Consumption and Growth Rate (2017-2022)
-
Table Europe Human Combination Vaccines Consumption and Growth Rate (2017-2022)
-
Figure China Human Combination Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Japan Human Combination Vaccines Consumption and Growth Rate (2017-2022)
-
Figure India Human Combination Vaccines Consumption and Growth Rate (2017-2022)
-
Figure South Korea Human Combination Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Global Human Combination Vaccines Consumption Forecast by Country (2022-2028)
-
Figure United States Human Combination Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Human Combination Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Human Combination Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Human Combination Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Human Combination Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Human Combination Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Human Combination Inactivated Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Global Human Combination Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Human Combination Inactivated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Human Combination Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Human Combination Vaccines Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Human Combination Vaccines Export by Region (Top 5 Countries) (2017-2028)
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Human Combination Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Human Combination Vaccines Product and Service
-
Table Takeda Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceuticals Human Combination Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceuticals Human Combination Vaccines Product and Service
-
Table Daiichi Sankyo (Foundation Year, Company Profile and etc.)
-
Table Daiichi Sankyo Human Combination Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daiichi Sankyo Human Combination Vaccines Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Human Combination Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Human Combination Vaccines Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Human Combination Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Human Combination Vaccines Product and Service
-
Table Serum Institute of India (Foundation Year, Company Profile and etc.)
-
Table Serum Institute of India Human Combination Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Serum Institute of India Human Combination Vaccines Product and Service
-
